Enthusiasm for its weight loss medications is intensifying, and several companies are preparing oral formulations.

Eli Lilly has launched its Mounjaro KwikPen in India at ₹14,000 for the 2.5 mg dose; the once-weekly injector targets ...

The stock market in 2025 resembles a chessboard of extremes. While volatility is shaking up markets, extraordinary ...

(Reuters) -Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight ...

The gush of second quarter earnings reports is beginning to slow to a trickle, and with most of the reports in, the results ...